Skip to main content

Nonprofit · EIN 58-6032060

AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC

Tax-exempt · ROCKVILLE, MD 20852

Financials

$5.7M$7.1M2023$6.7M$7.4M2024
Revenue Expenses · by fiscal year end
Financials of AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$6,734,604$7,360,722-$626,118$31,116,051$4,138,245$26,977,806
December 31, 2023990$5,712,373$7,144,205-$1,431,832$30,249,773$3,630,822$26,618,951
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$20,474
Program service revenue
$4,193,028
Investment income
$2,477,137
Net gain from sales of assets
$1,868,088
Other revenue
$43,965

Expenses

Grants and similar amounts paid
$276,000
Compensation of officers, directors and key employees
$603,964
Other salaries and wages
$2,142,710
Salaries, compensation and benefits (total)
$3,389,010
Professional fundraising fees
$0
Legal fees
$9,448
Accounting fees
$40,767
Occupancy
$185,989
Travel
$332,402
Depreciation
$52,106
Program services (functional)
$5,797,721
Management and general (functional)
$1,563,001

Balance sheet and other

Total assets, start of year
$30,249,773
Total assets, end of year
$31,116,051
Total liabilities, end of year
$4,138,245
Net assets, end of year
$26,977,806
Land, buildings and equipment
$200,042
Publicly traded securities
$29,537,653
Net assets without donor restrictions
$24,981,442
Net assets with donor restrictions
$1,996,364
Gross unrelated business income
$20,432
Gross receipts
$14,937,215
Employees
23
Volunteers
100
Year formed
1933
State of legal domicile
MD

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
DAVID JACKSONEXECUTIVE OFFICER
Officer
40$326,646$11,426
ROBERT STANLEYCHIEF FINANCIAL OFFICER
Officer
40$209,603$56,289
CATHERINE FRYEDUCATION DIRECTOR
Highest-paid employee
40$160,383$44,884
MARIA PASHOJOURNAL DIRECTOR
Highest-paid employee
40$162,240$41,282
MELISSA HUSTONMEETINGS DIRECTOR
Highest-paid employee
40$155,435$47,325
LYNNE HARRISMARKETING DIRECTOR
Highest-paid employee
40$167,331$16,041
CARTER ALLEMANGOVT AFFAIRS & SCIENCE POL DIRECTOR
Highest-paid employee
40$157,358$6,942
XINXIN DINGSEC/TREAS, THEN PAST SEC/TREAS
Trustee or director, Officer
5$25,525$0
NINA ISOHERRANENCOUNCILOR
Trustee or director
5$800$0
MICHAEL L JARVISPAST PRESIDENT (UNTIL 06/30/2024)
Trustee or director, Officer
5$0$0
NAMANDJE BUMPUSPRESIDENT
Trustee or director, Officer
5$0$0
KATHRYN CUNNINGHAMPAST SEC/TREAS (UNTIL 06/30/2024)
Trustee or director, Officer
5$0$0
CAROL BECKPRESIDENT ELECT
Trustee or director, Officer
5$0$0
PAM HORNBYSEC/TREAS ELECT, THEN SEC/TREAS
Trustee or director, Officer
5$0$0
RANDY HALLCOUNCILOR, THEN PRESIDENT ELECT
Trustee or director
5$0$0
3 more people on this return
NameTitleHours / weekCompensation
JOHN TRAYNORCOUNCILOR, THEN SEC/TREAS ELECT
Trustee or director
5$0
KENNETH TEWCOUNCILOR, THEN SEC/TREAS ELECT
Trustee or director
5$0
AMY ARNOLDCOUNCILOR (AS OF 06/30/2024)
Trustee or director
5$0
990 for the year ended December 31, 2023: 17 people
NameTitleHours / weekCompensationOther / benefits
DAVID JACKSONEXECUTIVE OFFICER
Officer
40$305,502$10,959
ROBERT STANLEYCHIEF FINANCIAL OFFICER
Officer
40$203,566$40,419
CATHERINE FRYEDUCATION DIRECTOR
Highest-paid employee
40$152,636$33,727
MARIA PASHOJOURNAL DIRECTOR
Highest-paid employee
40$161,777$22,365
MELISSA HUSTONMEETINGS DIRECTOR
Highest-paid employee
40$150,741$28,675
LYNNE HARRISMARKETING DIRECTOR
Highest-paid employee
40$152,835$15,170
CARTER ALLEMANGOVT AFFAIRS & SCIENCE POL DIRECTOR
Highest-paid employee
40$146,577$5,103
XINXIN DINGSEC/TREAS ELECT, THEN SEC/TREAS
Trustee or director, Officer
5$35,000$0
MICHAEL L JARVISPRESIDENT, THEN PAST PRESIDENT
Trustee or director, Officer
5$0$0
NAMANDJE BUMPUSPRESIDENT ELECT, THEN PRESIDENT
Trustee or director, Officer
5$0$0
MARGARET GNEGYPAST PREDIDENT
Trustee or director, Officer
5$0$0
KATHRYN CUNNINGHAMSEC/TREAS, THEN PAST SEC/TREAS
Trustee or director, Officer
5$0$0
CAROL BECKPAST SEC/TREAS, THEN PRES ELECT
Trustee or director, Officer
5$0$0
PAM HORNBYSEC/TREAS ELECT
Trustee or director, Officer
5$0$0
RANDY HALLCOUNCILOR
Trustee or director
5$0$0
JOHN TRAYNORCOUNCILOR
Trustee or director
5$0$0
NINA ISOHERRANENCOUNCILOR
Trustee or director
5$0$0

Address and contacts

Address (IRS master file)
1801 ROCKVILLE PIKE STE 210, ROCKVILLE, MD 20852-1633
Principal officer (990 for 2024)
DAVID JACKSON, 1801 ROCKVILLE PIKE 210, ROCKVILLE, MD 20852
Signed the 990
DAVID JACKSON, EXECUTIVE OFFICER
Phone
(301) 634-7065
Return prepared by
COUNCILOR BUCHANAN & MITCHELL PC

Mission

THE AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (ASPET) IS A 4,000 MEMBER SCIENTIFIC SOCIETY WHOSE MEMBERS CONDUCT BASIC AND CLINICAL PHARMACOLOGICAL RESEARCH AND WORK FOR ACADEMIA, GOVERNMENT, LARGE PHARMACEUTICAL COMPANIES, SMALL BIOTECH COMPANIES, AND NON-PROFIT ORGANIZATIONS.

990 for the year ended December 31, 2024

Program accomplishments

  • PUBLICATIONS - THE SOCIETY PUBLISHES SCIENTIFIC AND EDUCATIONAL JOURNALS AND OTHER PUBLICATIONS FOR THE SCIENTIFIC COMMUNITY INCLUDING THE FOLLOWING:JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - MONTHLY RESEARCH PUBLICATION COVERING TOPICS INCLUDING THE INTERACTIONS OF CHEMICALS WITH BIOLOGICAL SYSTEMS, INCLUDING AUTONOMIC, BEHAVIORAL, CARDIOVASCULAR, CELLULAR, CLINICAL, DEVELOPMENTAL, GASTROINTESTINAL, IMMUNO-, NEURO-, PULMONARY AND RENAL PHARMACOLOGY, AS WELL AS ANALGESICS, DRUG ABUSE, METABOLISM AND DISPOSITION, CHEMOTHERAPY, AND TOXICOLOGY.PHARMACOLOGICAL REVIEWS - QUARTERLY REVIEW JOURNAL COVERING CONCENTRATIONS IN PHARMACOLOGY, EXPERIMENTAL THERAPEUTICS, TOXICOLOGY, AND CHEMOTHERAPY.MOLECULAR PHARMACOLOGY - MONTHLY PUBLICATION WITH AN EMPHASIS ON RESEARCH OF DRUG ACTION AND SELECTIVE TOXICITY AT THE MOLECULAR LEVEL. ORIGINAL APPLICATIONS OF BIOCHEMISTRY, BIOPHYSICS, GENETICS AND MOLECULAR BIOLOGY ARE COMBINED WITH PHARMACOLOGIC RESEARCH TO SOLVE BASIC PROBLEMS IN PHARMACOLOGY AND TOXICOLOGY.DRUG METABOLISM AND DISPOSITION - MONTHLY PUBLICATION COVERING THE FIELDS OF PHARMACOKINETICS, PHARMACODYNAMICS AND MECHANISMS, GENETIC NUTRITIONAL OR HORMONAL FACTORS AFFECTING THE BIOLOGICAL FATE OF CHEMICALS, AND THE TOXICOLOGICAL CONSEQUENCES OF XENOBIOTIC METABOLISM.THE PHARMACOLOGIST - MONTHLY PUBLICATION WITH THE PURPOSE OF INFORMING PHARMACOLOGISTS ABOUT SOCIETY AFFAIRS AND OTHER MATTERS OF PROFESSIONAL INTEREST. DISTRIBUTED ELECTRONICALLY TO ASPET MEMBERS AND MAILED TO NONMEMBER SUBSCRIBERS AS WELL AS MEMBERS WHO PAY FOR A PRINT SUBSCRIPTION.
    Expenses $1,918,957 · revenue $3,370,443
  • MEETINGS - THE SOCIETY HOSTS AN ANNUAL MEETING EACH YEAR IN A DIFFERENT PART OF THE US PROVIDING A FORUM FOR SCIENTISTS TO COMMUNICATE AND EXCHANGE PHARMACOLOGICAL KNOWLEDGE THROUGH SCIENTIFIC SESSIONS. SMALLER FOCUSED MEETINGS ARE HELD ON AN OCCASIONAL BASIS AS THE NEED ARISES.
    Expenses $1,575,137 · revenue $470,060
  • MARKETING - TO PROMOTE ASPET'S PROGRAMS AND SERVICES, PRODUCE THE PHARMACOLOGIST, ASPET'S MONTHLY NEWSLETTER, PROMOTE MEMBERSHIPS AND THE ANNUAL MEETING.
    Expenses $596,559
  • AWARDS - THE SOCIETY OFFERS THREE TYPES OF AWARDS TO DISTINGUISHED PHARMACOLOGISTS AND TO STUDENTS AND YOUNG SCIENTISTS IN THE FIELD. SCIENTIFIC AWARDS ARE PROVIDED TO RECOGNIZE AND ENCOURAGE OUTSTANDING RESEARCH BY PROMINENT PHARMACOLOGISTS AND TO STIMULATE FUNDAMENTAL RESEARCH BY YOUNG INVESTIGATORS. BEST POSTER AWARDS ARE PRESENTED TO MEETING ATTENDEES WHO HAVE SUBMITTED AN OUTSTANDING RESEARCH ABSTRACT FOR PRESENTATION AT THE MEETING. TRAVEL AWARDS ARE GRANTED TO STUDENTS AS AN EDUCATIONAL TOOL TO ATTEND SCIENTIFIC MEETINGS.
    Expenses $579,747 · grants $276,000
  • MEMBER SERVICES - INCLUDES MEMBERSHIP COMMUNICATIONS AND DIVISIONS TO ADDRESS SPECIFIC AREAS OF CONCERN OR INTEREST TO THE MEMBER PHARMACOLOGISTS IN THE SOCIETY. NOMINATION AND ELECTION OF NEW MEMBERS, DEVELOPMENT OF EDUCATIONAL ACTIVITIES RELEVANT TO THE PROMOTION AND ADVANCEMENT OF THE SCIENTIFIC DISCIPLINE. WEB SITE PROVIDES AN INTERFACE BETWEEN MEMBERS AND THE SOCIETY AS WELL AS INFORMATION TO INDIVIDUALS WISHING TO LEARN MORE ABOUT THE FIELD OF PHARMACOLOGY.
    Expenses $552,436 · revenue $352,525
  • PUBLIC SERVICES - PROVIDES INFORMATION TO THE GENERAL PUBLIC ABOUT PHARMACOLOGY AND SCIENTIFIC ACHIEVEMENTS AND NEEDS IN THE FIELD. OFFICERS AND MEMBERS PROVIDE A RESOURCE TO THE COMMUNITY WHEN THERE IS A NEED FOR SPECIALIZED EXPERTISE. THE EDUCATION DIVISION CONDUCTS SPECIAL SESSIONS DEVOTED TO IMPROVING EDUCATION IN THE PHARMACOLOGICAL SCIENCES.
    Expenses $314,752
  • EDUCATIONAL AFFAIRS - SUPPORTS SUMMER UNDERGRADUATE RESEARCH FELLOWSHIPS IN THE FIELD OF PHARMACOLOGY.
    Expenses $260,133

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
58-6032060
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1938
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E66P)
Assets (IRS master file)
$31,116,051
Income (IRS master file)
$14,937,215

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$6,734,604$7,360,722$31,116,051XML
990-TDecember 2024–––IRS
990December 2023$5,712,373$7,144,205$30,249,773XML
990-TDecember 2023–––IRS
990December 2022$4,463,274$5,114,519$29,344,018IRS
990-TDecember 2022–––IRS
990December 2021–––IRS
990-TDecember 2021–––IRS
990December 2020–––IRS
990-TDecember 2020–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 58-6032060).

Questions about AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC

What is the EIN of AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC?
The employer identification number (EIN) of AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC is 58-6032060.
Is AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1938.
Are donations to AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC?
The 990 for the year ended December 31, 2024 names DAVID JACKSON.
Who are the officers and directors of AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC?
The 990 for the year ended December 31, 2024 lists 18 people; 9 received compensation from the organization, the highest $326,646 (DAVID JACKSON, EXECUTIVE OFFICER).
How much revenue does AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $6,734,604, expenses of $7,360,722 and total assets of $31,116,051 at year end.

Other nonprofits in ROCKVILLE

All nonprofits in ROCKVILLE · Maryland · Health care